Note: Ingredients listed on restricted chemical lists
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
General Information
Revision date
2020-09-10
Product name
PITT-TECH PLUS SATIN DEEP TONE BASE
supplier name
PPG Canada Inc
Emergency telephone
(412) 434-4515 (U.S.
Icons in SDS
Company Information
company name
PPG Canada Inc
GHS Information
Signal word
Warning
Section 2
2.1 Classification of the substance or mixture
CARCINOGENICITY - Category 2 This product contains TiO2 which has been classified as a GHS Carcinogen Category 2 based on its IARC 2B classification. For many PPG products, TiO2 is utilized as a raw material in a liquid coating formulation. In this case, the TiO2 particles are bound in a matrix with no meaningful potential for human exposure to unbound particles of TiO2 when the product is applied with a brush or roller. Sanding the coating surface or mist from spray applications may be harmful depending on the duration and level of exposure and require the use of appropriate personal protective equipment and/or engineering controls (see Section 8).
Signal word
Warning
Hazard statements
Suspected of causing cancer.
Precautionary statements
General : Read label before use. Keep out of reach of children. If medical advice is needed, have product container or label at hand.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection.
Response
IF exposed or concerned: Get medical advice or attention.
Storage
Store locked up.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Contains isothiazolinones. May cause allergic reaction. Emits toxic fumes when elements heated. Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 30.5% (oral), 42.2% (dermal), 45.1% (inhalation)